Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Non-Current Debt (2016 - 2025)

Conmed (CNMD) has disclosed Non-Current Debt for 16 consecutive years, with $834.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Debt fell 7.83% year-over-year to $834.2 million, compared with a TTM value of $834.2 million through Dec 2025, down 7.83%, and an annual FY2025 reading of $834.2 million, down 7.83% over the prior year.
  • Non-Current Debt was $834.2 million for Q4 2025 at Conmed, down from $853.0 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $1.0 billion in Q3 2022 and bottomed at $672.4 million in Q4 2021.
  • Average Non-Current Debt over 5 years is $882.9 million, with a median of $922.6 million recorded in 2024.
  • The sharpest move saw Non-Current Debt decreased 10.45% in 2021, then soared 47.36% in 2022.
  • Year by year, Non-Current Debt stood at $672.4 million in 2021, then surged by 46.5% to $985.1 million in 2022, then dropped by 1.21% to $973.1 million in 2023, then dropped by 7.0% to $905.1 million in 2024, then fell by 7.83% to $834.2 million in 2025.
  • Business Quant data shows Non-Current Debt for CNMD at $834.2 million in Q4 2025, $853.0 million in Q3 2025, and $881.1 million in Q2 2025.